Scientific Industries, Inc. (SCND)

OTCMKTS · Delayed Price · Currency is USD
0.7500
-0.0500 (-6.25%)
At close: May 7, 2026
Market Cap8.95M -35.5%
Revenue (ttm)5.05M +5.4%
Net Income-1.22M
EPS-0.11
Shares Out11.93M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume735
Average Volume2,188
Open0.7500
Previous Close0.8000
Day's Range0.7500 - 0.7500
52-Week Range0.3000 - 0.9762
Beta0.33
RSI53.33
Earnings DateMay 12, 2026

About Scientific Industries

Scientific Industries, Inc. engages in the design, manufacture, and marketing of standard benchtop laboratory equipment, weight and measurement, and bioprocessing products in the United States, Germany, and internationally. The company offers laboratory vortex mixers, shakers, and accessories; rotators and rockers accessories; disruptors and shakers accessories; as well as incubators under the Genie brand name. It also provides pharmacy, laboratory, industrial digital scales, moisture analyzers, mechanical and automated pill counters, force gau... [Read more]

Sector Technology
Founded 1954
Employees 67
Stock Exchange OTCMKTS
Ticker Symbol SCND
Full Company Profile

Financial Performance

In 2025, Scientific Industries's revenue was $5.05 million, an increase of 5.35% compared to the previous year's $4.80 million. Losses were -$1.22 million, -81.07% less than in 2024.

Financial Statements

News

Scientific Industries Earnings Call Transcript: Q3 2025

Q3 2025 saw record revenue, driven by strong sales in bioprocessing and new AI-driven product features. The company completed the Genie division divestiture and is focused on expanding its DOTS and VIVID platforms, despite ongoing market caution and selective capital spending.

6 months ago - Transcripts

Scientific Industries Announces Third Quarter 2025 Results And Launch of VIVID's New AI-Powered Feature

TORBAL DIVISION SALES UP 15% YTD LAUNCH OF VIVID'S FIRST AI-POWERED FEATURE SECOND GENERATION VIVID-ONE LAUNCH SCHEDULED FOR Q1 CY26

6 months ago - GlobeNewsWire

Scientific Industries to Host Third Quarter Fiscal Year 2025 Financial Results Investor Call on November 20, 2025

BOHEMIA, N.Y., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a developer of digitally simplified bioprocessing products and vision-based pill counters, announced it will...

6 months ago - GlobeNewsWire

Scientific Industries Transcript: Lytham Partners Fall 2025 Investor Conference

The company has transformed into a digital and AI-focused life science innovator, divesting legacy assets to invest in pharmacy automation and bioprocessing. With strong financials, a robust product roadmap, and major industry partnerships, it targets rapid growth and leadership in AI-enabled scientific tools.

7 months ago - Transcripts

Scientific Industries to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025

BOHEMIA, N.Y., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a developer of digitally simplified bioprocessing products and vision-based pill counters, today announced ...

8 months ago - GlobeNewsWire

Scientific Industries Earnings Call Transcript: Q2 2025

Legacy Genie division sold, shifting focus to AI-driven life science and bioprocessing. Q2 revenue rose 66% sequentially but lagged year-over-year, with academic sales sharply down. R&D and commercial engagement remain strong despite industry headwinds.

9 months ago - Transcripts

Scientific Industries Reports Financial Results for Second Quarter of Fiscal Year 2025

TORBAL DIVISION SALES UP 11% SECURED $10 MILLION IN STRATEGIC DIVESTURE OF GENIE PRODUCT LINE VIVID AND BIOPROCESSING NEW PRODUCT AI ROADMAP ON TARGET

9 months ago - GlobeNewsWire

Scientific Industries to Host Second Quarter Fiscal Year 2025 Financial Results Investor Call on August 20, 2025

BOHEMIA, N.Y., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a developer of digitally simplified bioprocessing products and vision-based pill counters, announced it will...

9 months ago - GlobeNewsWire

Scientific Industries Completes Strategic Refocus and Secures Proceeds of $10 million to Accelerate Growth of Two Data-Driven Business Platforms; Divests Genie® Division to OHAUS Corporation's affiliate Troemner, LLC

Realign priorities - AI-powered platforms to accelerate innovation and market leadership Driving transformation in pharmacy automation with VIVID's advanced solutions Advancing AI-powered biomanufactu...

9 months ago - GlobeNewsWire

Scientific Industries Transcript: Lytham Partners Spring 2025 Investor Conference

The company is advancing digital automation in life science labs, launching new AI-enabled products and expanding its bioprocessing platform to reduce experiment costs and increase data output. With a strong financial position and major industry validation, it targets rapid growth and break-even by 2027.

1 year ago - Transcripts

Scientific Industries to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025

BOHEMIA, N.Y., May 27, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced it w...

1 year ago - GlobeNewsWire

Scientific Industries Earnings Call Transcript: Q1 2025

Q1 2025 saw strong benchtop equipment sales and increased U.S. demand, but bioprocessing revenue declined due to funding delays and longer sales cycles. Despite macroeconomic headwinds, new financing, product launches, and a robust sales pipeline position the company for growth later in 2025.

1 year ago - Transcripts

Scientific Industries Reports Financial Results for First Quarter of Fiscal Year 2025

BENCHTOP LAB EQUIPMENT SALES UP 5% FIRST PEER-REVIEWED PUBLICATION ON COMPANY'S DOTS MPS BIOPROCESSING PLATFORM RECORD NUMBER OF BIOPROCESSING SALES OPPORTUNITIES Investor Call to be held Wednesday, M...

1 year ago - GlobeNewsWire

Scientific Industries to Host First Quarter Fiscal Year 2025 Financial Results Investor Call on May 14, 2025

BOHEMIA, N.Y., May 12, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced it w...

1 year ago - GlobeNewsWire

Scientific Industries Secures New Funding to Advance its SBI Bioprocessing Division

BOHEMIA, N.Y., April 22, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced to...

1 year ago - GlobeNewsWire

Scientific Industries Earnings Call Transcript: Q4 2024

Fiscal 2024 saw operational streamlining, new product launches, and strong bioprocessing growth, with a 24% sales increase and a robust pipeline for 2025. The company reduced costs, improved margins, and is positioned for further expansion as industry conditions recover.

1 year ago - Transcripts

Scientific Industries to Host Fiscal Year 2024 Financial Results Investor Call on April 1, 2025

BOHEMIA, N.Y., April 01, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced it...

1 year ago - GlobeNewsWire

Scientific Industries Reports Financial Results for Fiscal Year Ended December 31, 2024 and Launches DOTS MPS for Cell Culture Biopharma Market

BIOPROCESSING OPERATIONS: 24% REVENUE GROWTH DRIVEN BY NEWLY LAUNCHED PRODUCTS OPERATIONAL EFFICIENCIES CUT TOTAL NET LOSSES BY 29% LAUNCHED NEW STATE OF THE ART VIVID WORKSTATION Investor Call to be ...

1 year ago - GlobeNewsWire

Scientific Industries Earnings Call Transcript: Q3 2024

Sales rebounded in core and new product lines, with Vivid Pill Counter up 50% sequentially and bioprocessing U.S. revenue up 61% year-to-date. Cost reductions improved EBITDA and productivity, while new product launches and major account wins position the company for future growth.

1 year ago - Transcripts

Scientific Industries, Inc reports Q3 EPS (11c) vs. (31) last year

Reports Q3 revenue $2.8M vs. $2.6M last year. John Moore, Chairman, said, “The third quarter was the best in the history of Scientific Bioprocessing. After only five months on the

1 year ago - TheFly

Scientific Industries Reports Third Quarter 2024 Financial Results

BIOPROCESSING OPERATIONS RECORDS 3 CONSECUTIVE QUARTERS OF REVENUE GROWTH OPERATIONAL EFFICIENCIES CUT QUARTER AND YTD NET LOSSES BY 46% AND 34% TWO MAJOR NEW PRODUCTS TO LAUNCH IN Q1 2025 Investor Ca...

1 year ago - GlobeNewsWire

Scientific Industries to Host Third Quarter 2024 Financial Results Investor Call on November 15, 2024

BOHEMIA, N.Y., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced tod...

1 year ago - GlobeNewsWire

Scientific Industries to Present at the Craig-Hallum Bioprocessing Conference on September 19, 2024

Fireside Chat to be held at 12:30 p.m. Eastern Time BOHEMIA, NY / ACCESSWIRE / September 17, 2024 / Scientific Industries, Inc. (OTCQB:SCND), a life sciences tool provider, and a developer of digitall...

1 year ago - Accesswire

Scientific Industries Earnings Call Transcript: Q2 2024

Genie and Torbal product lines rebounded after industry disruptions, with rapid growth expected from the VIVID Workstation launch. Bioprocessing saw 16% sales growth and 20% EBITDA improvement in H1, driven by strong U.S. performance and cost savings, while the DOTS platform gained early industry endorsement.

1 year ago - Transcripts

Scientific Industries, Inc reports Q2 EPS (12c) vs. (33c) last year

Reports Q2 revenue $2.6M vs. $3M last year. Helena Santos, Chief Executive Officer of Scientific Industries, stated, “We are optimistic as we enter the second half of 2024 with strong

1 year ago - TheFly